You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

drug/agent toxicity by tissue/organ

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

Withdrawn
  • Drug/Agent Toxicity by Tissue/Organ
  • +3 more
  • amifostine trihydrate
  • +2 more
  • Chicago, Illinois
  • +3 more
Jan 31, 2023

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

Completed
Has Results
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • Boston, Massachusetts
  • +9 more
Nov 9, 2022

Cytomegalovirus Infections, Infection in Solid Organ Transplant Recipients, Neutropenia Trial (Letermovir)

Not yet recruiting
  • Cytomegalovirus Infections
  • +3 more
  • (no location specified)
Jan 17, 2023

Maximum Tolerated Dose, GIST, Metastatic Adult Soft Tissue Sarcoma Trial in Spain (Selinexor, Imatinib)

Recruiting
  • Maximum Tolerated Dose
  • +4 more
  • Sevilla, Andalucia, Spain
  • +5 more
Oct 21, 2020

Postoperative Pain, Gynecologic Disease, Local Anesthetic Systemic Toxicity Trial in Kuala Lumpur (Lignocaine, Normal Saline)

Not yet recruiting
  • Postoperative Pain
  • +2 more
  • Kuala Lumpur, Malaysia
    University of Malaya
May 31, 2023

Endocrine Autoimmune Toxicity Due to Immune Checkpoint

Recruiting
  • Thyroid
  • +2 more
    • New York, New York
      Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment C
    Oct 25, 2022

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023

    End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet

    Completed
    • End Stage Renal Disease
    • Rejection of Renal Transplant
    • Tacrolimus
    • Tacrolimus Extended Release Oral Tablet [Envarsus]
    • Chicago, Illinois
      Northwestern University
    Jan 12, 2023

    Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma Trial in Pittsburgh (Microneedle Array Doxorubicin

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Skin Cancers - Squamous Cell Carcinoma
    • Microneedle Array Doxorubicin (MNA-D)
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Nov 28, 2022

    Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)

    Completed
    Has Results
    • Lymphoma, T-Cell
    • Lymphoma, Extranodal NK-T-Cell
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Feb 3, 2022

    Hypotension Trial (Noradrenalin, Phenylephrine)

    Not yet recruiting
    • Hypotension
    • (no location specified)
    Oct 9, 2023

    Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

    Not yet recruiting
    • Sarcoma, Ewing
    • Rhabdomyosarcoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Ovarian Cancer Trial in Xiamen (Organoid culture)

    Recruiting
    • Ovarian Cancer
    • Organoid culture
    • Xiamen, Fujian, China
      First Affiliated Hospital of Xiamen University
    Apr 3, 2023

    Inhalation Anesthesia, Dexmedetomidine, Sevoflurane Trial in Montréal (Dexmedetomidine, Placebo)

    Not yet recruiting
    • Inhalation Anesthesia
    • +3 more
    • Montréal, Quebec, Canada
      Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est de l'Ile de Montré
    Nov 14, 2022

    Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)

    Recruiting
    • Soft Tissue Sarcoma
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in

    Active, not recruiting
    • Castration-Resistant Prostate Carcinoma
    • +5 more
    • Questionnaire Administration
    • Tin Sn 117m Pentetate
    • Lexington, Kentucky
      University of Kentucky/Markey Cancer Center
    Nov 26, 2022

    Refractory Solid Organ Malignancies Trial in Singapore (DRUID AI Program)

    Not yet recruiting
    • Refractory Solid Organ Malignancies
    • DRUID AI Program
    • Singapore, Singapore
      Department of Hematology-Oncology, National University Hospital
    Jan 30, 2023

    Breast Cancer Stage IV Trial in Iowa City, New Delhi, Chandigarh (Lutetium-177-PEG-avß3-IAC)

    Not yet recruiting
    • Breast Cancer Stage IV
    • Iowa City, Iowa
    • +2 more
    Jun 7, 2022

    Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

    Not yet recruiting
    • Relapsed/Refractory Non-Hodgkin Lymphoma
    • Duarte, California
    • +1 more
    Oct 13, 2023

    Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

    Recruiting
    • Oncolytic Virus
    • +2 more
    • Ad-TD-nsIL12
    • Beijing, Beijing, China
      Sanbo Brain Hospital, Capital Medical University
    Jan 29, 2023

    Tumors Trial run by the NCI (Nilotinib and Paclitaxel)

    Recruiting
    • Neoplasms
    • Nilotinib and Paclitaxel
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

    Not yet recruiting
    • Pancreas Cancer
    • Non-Resectable Pancreas Carcinoma
    • Aalborg, Denmark
      Department of Oncology, Aalborg University Hospital
    May 1, 2023

    Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

    Recruiting
    • Oncolytic Virus
    • +2 more
    • Ad-TD-nsIL12
    • Beijing, Beijing, China
      Sanbo Brain Hospital, Capital Medical University
    Jan 29, 2023

    Non-Squamous NSCLC (NSCLC), Adenocarcinoma of the Lung, Lung Cancer Trial in United States (Docetaxel, Nivolumab, Gemcitabine)

    Terminated
    Has Results
    • Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
    • +3 more
    • Anderson, Indiana
    • +8 more
    Jul 7, 2022

    Coronary Artery Disease Trial in Japan (Device: Paclitaxel-Coated PTCA Balloon Catheter, SeQuent Please Drug Eluting Balloon

    Active, not recruiting
    Has Results
    • Coronary Artery Disease
    • Device: Paclitaxel-Coated PTCA Balloon Catheter
    • SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel
    • Kitakyushu, Fukuoka, Japan
    • +13 more
    Dec 2, 2022